Sign In
NewsRadar

PolyTherics, Ltd.

PolyTherics is to using biomedical polymers to optimise pharmaceuticals, in particular biopharmaceuticals, for the treatment and cure of the world's most important diseases. PolyTherics' most advanced programmes are designed to exploit TheraPEG™ technology, a patent protected approach to the PEGylation of therapeutic proteins and antibody fragments.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Web:
Contact:
 
 
The London BioScience Innovation Centre
2 Royal College Street
London NW1 0TU
United Kingdom
+44 (0)207 691 4928
http://www.polytherics.co.uk
Keith Powell
+44 (0)207 691 4928

Company Facts
Founded:Dec 2002
Founders:Steve Brocchini, Sunil Shaunak
CEO:Keith Powell
CTO or technical lead:
CFO or finance director:
Head of Sales:Debbie Allen
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,569
Tech investments
From our Online Data Service
17,158
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Jan 10€20.0MBusiness applications
Jan 10€20.0MBiotechnology
Jan 10€13.5MArtificial Intelligence
Jan 9€4.0MSoftware development
Jan 9N/AInternet services
Jan 9€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.